Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...

Eli Lilly (NYSE: LLY) has been a growth beast over the years and is now easily the most valuable healthcare company in the ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

The Fluor team constructing the Eli Lilly and Co. pharmaceutical complex on Lebanon's north side recognized national Safety ...

Winkler said her company would like to help New Palestine leaders be more intentional with their branding. Winkler said the ...

Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...

But shares of Eli Lilly have gained about 800% since that same month, when CEO Dave Ricks took over the company. Mounting pressure also came from the powerful Novo Nordisk Foundation ...

While Eli Lilly entered the market ... time to find a new CEO following the foundation's request, recent market challenges and the steep decline in the company's share price.

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from US rival Eli Lilly ... The company is controlled by the Novo Nordisk Foundation ...